Financial Report
1 January - 31 December
|
kEUR |
2023 |
2022 |
|
|
|
|
|
|
|
Result for the year |
|
-51,440 |
7,767 |
|
|
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
7,713 |
4,834 |
|
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
7,713 |
4,834 |
|
|
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
3,269 |
13,526 |
|
|
Income tax effect |
-836 |
-3,174 |
|
|
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
2,433 |
10,352 |
|
Other comprehensive result for the year, net of taxes |
|
10,146 |
15,186 |
|
|
|
|
|
|
Total comprehensive result for the year, net of taxes |
|
-41,294 |
22,953 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
-41,294 |
22,953 |